Benefits of switching from latanoprost to preservative-free tafluprost eye drops: a meta-analysis of two Phase IIIb clinical trials
Hannu Uusitalo,1 Evgeniy Egorov,2 Kai Kaarniranta,3 Yuri Astakhov,4 Auli Ropo5 On behalf of the Switch Study Tafluprost Study Groups 1Department of Ophthalmology, SILK, University of Tampere, Tampere University Hospital, Tampere, Finland; 2Department of Ophthalmology, The Russian National Research...
Saved in:
Main Authors: | Uusitalo H, Egorov E, Kaarniranta K, Astakhov Y, Ropo A |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2016
|
Subjects: | |
Online Access: | https://doaj.org/article/318b9db2728f4009bca78d6c06d9b94c |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The signs of ocular-surface disorders after switching from latanoprost to tafluprost/timolol fixed combination: a prospective study
by: Okumichi H, et al.
Published: (2017) -
Ocular Surface Changes After Switching from Other Prostaglandins to Tafluprost and Preservative-Free Tafluprost in Glaucoma Patients
by: Ruangvaravate N, et al.
Published: (2020) -
Better tolerance of preservative-free latanoprost compared to preserved glaucoma eye drops: the 12-month real-life FREE study
by: Economou MA, et al.
Published: (2018) -
Preservative-free fixed combination of tafluprost 0.0015% and timolol 0.5% in patients with open-angle glaucoma and ocular hypertension: results of an open-label observational study
by: Pillunat LE, et al.
Published: (2017) -
Real-World Study on Patient Satisfaction and Tolerability After Switching to Preservative-Free Latanoprost
by: Erb C, et al.
Published: (2021)